Comparison of different dosing regimens (once weekly <it>vs</it>. twice weekly, and once weekly <it>vs</it>. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Anaemia is a common complication of chronic kidney disease and prevalence increases with declining renal function. Renal anaemia has significant implications for the well-being and quality of life of patients and impacts on morbidity...
Main Author: | Macdougall Iain C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-11-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/8/1/35 |
Similar Items
-
Incremental and Once- to Twice-Weekly Hemodialysis: From Experience to Evidence
by: Yoshitsugu Obi, et al.
Published: (2017-09-01) -
Effects of Exenatide Twice Daily and Once Weekly on Weight Loss
by: Patel, Rajal, et al.
Published: (2013) -
Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
by: Toshitsugu Sugimoto, et al.
Published: (2021-03-01) -
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
by: Chiquette E, et al.
Published: (2012-11-01) -
Once-a-week versus once-every-3-weeks cisplatin in patients receiving chemoradiation for locally advanced head-and-neck cancer: A survey of practice in India
by: Gautam Goyal, et al.
Published: (2018-01-01)